Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20170623001
TCTR20170623001
Recruiting
Phase 3

Impact of dialysate calcium concentration on intradialytic left ventricular systolic function: A randomized controlled study

Renal Division, Department of Internal Medicine, Chiang Mai University0 sites82 target enrollmentJune 23, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Renal Division, Department of Internal Medicine, Chiang Mai University
Enrollment
82
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 23, 2017
End Date
January 31, 2018
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Renal Division, Department of Internal Medicine, Chiang Mai University

Eligibility Criteria

Inclusion Criteria

  • •\- Age more than 18 years old
  • •\- End\-stage renal disease (defined by estimated glomerular filtration rate \<15 ml/min/1\.73 m2 which require long\-term hemodialysis
  • •\- Hemodialysis vintage of more than 3 months
  • •\- Hemodialysis 3 sessions per week

Exclusion Criteria

  • •\- \>2 episodes of intradialytic hypotension which required immediate treatment prior to randomization
  • •\- Active cardiac disease (e.g., acute myocardial infarction, heart failure, arrhythmia)
  • •\- Sepsis/septic shock
  • •\- Require ultrafiltration more than 3\.5 L/session
  • •\- Active malignancy
  • •\- Documented reduced left ventricular ejection fraction (LVEF \<30%) prior to enrollment
  • •\- Documented vascular calcification prior to enrollment
  • •\- Hypercalcemia (serum calcium \>10\.5 mg/dl) or hypocalcemia (serum calcium \<7 mg/dl) prior to enrollment

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Effect of dialystate sodium concentration on intracellular and extracellular fluid volumes in regular chronic haemodialysis (HD) patients
ISRCTN14411549Record Provided by the NHSTCT Register - 2007 Update - Department of Health13
Completed
Not Applicable
The impact of coversion of dialysate calcium concentration from either 2.5 mEq/L or 3.0 mEq/L to 2.75 mEq/L on mineral and bone disorders in maintenance hemodialysis patients: the K4 Study
JPRN-UMIN000035184Fukuoka Renal Clinic24
Completed
Not Applicable
Effect of calcium and citrate dialysate concentrations on the calcification propensity in hemodialysis; a prospective randomized controlled cross-over trial.Calcification propensity of serum of hemodialysis patients. Vascular calcification.100132961003843010003216
NL-OMON44984Interne Geneeskunde, Nefrologie20
Completed
Not Applicable
The calcification propensity of uremic patients on hemodialysis.Calcification propensity. Dialysis. Vascular Calcification.
NL-OMON28230Maastricht University Medical CenterPO Box 58006202 AZ Maastricht, The Netherlands20
Completed
Not Applicable
The effect of conversion of dialysate calcium concentration from 3.0 mEq/L to 2.5 mEq/L on mineral and bone disorder in chronic hemodialysis patientsChronic kidney disease-Mineral and Bone Disorder
JPRN-UMIN000015153Fukuoka Dental College100